218 related articles for article (PubMed ID: 17685890)
1. Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer.
Papadavid E; Stratigos AJ; Falagas ME
Expert Opin Pharmacother; 2007 Aug; 8(11):1743-55. PubMed ID: 17685890
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases.
Ulrich C; Busch JO; Meyer T; Nindl I; Schmook T; Sterry W; Stockfleth E
Br J Dermatol; 2006 Aug; 155(2):451-4. PubMed ID: 16882188
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod in dermatology: an overview.
Hanna E; Abadi R; Abbas O
Int J Dermatol; 2016 Aug; 55(8):831-44. PubMed ID: 27387373
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases.
Stockfleth E; Meyer T; Benninghoff B; Christophers E
Br J Dermatol; 2001 May; 144(5):1050-3. PubMed ID: 11359396
[TBL] [Abstract][Full Text] [Related]
5. Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions.
Wagstaff AJ; Perry CM
Drugs; 2007; 67(15):2187-210. PubMed ID: 17927284
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod in basal cell carcinoma: how does it work?
Dummer R; Urosevic M; Kempf W; Hoek K; Hafner J; Burg G
Br J Dermatol; 2003 Nov; 149 Suppl 66():57-8. PubMed ID: 14616353
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studies.
Gupta AK; Davey V; Mcphail H
J Cutan Med Surg; 2005 Oct; 9(5):209-14. PubMed ID: 16502198
[TBL] [Abstract][Full Text] [Related]
8. Imiquimod (Aldara) for actinic keratoses.
Med Lett Drugs Ther; 2004 May; 46(1183):42-4. PubMed ID: 15159659
[No Abstract] [Full Text] [Related]
9. Microarray analysis of aberrant gene expression in actinic keratosis: effect of the Toll-like receptor-7 agonist imiquimod.
Torres A; Storey L; Anders M; Miller RL; Bulbulian BJ; Jin J; Raghavan S; Lee J; Slade HB; Birmachu W
Br J Dermatol; 2007 Dec; 157(6):1132-47. PubMed ID: 17944981
[TBL] [Abstract][Full Text] [Related]
10. [Solar keratosis: from precancerous lesion to pre-invasive squamous cell carcinoma--therapeutic approach with a bioinductive method].
Oster-Schmidt C; Altmeyer P; Markus S
J Dtsch Dermatol Ges; 2003 Oct; 1(10):790-6. PubMed ID: 16281815
[TBL] [Abstract][Full Text] [Related]
11. Imiquimod 5% cream for actinic keratosis.
Perras C
Issues Emerg Health Technol; 2004 Sep; (61):1-4. PubMed ID: 15382379
[TBL] [Abstract][Full Text] [Related]
12. [New perspective in immunotherapy: local imiquimod treatment].
Kemény L; Nagy N
Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive imaging, treatment, and microscopic confirmation of clearance of basal cell carcinoma.
Goldgeier M; Fox CA; Zavislan JM; Harris D; Gonzalez S
Dermatol Surg; 2003 Mar; 29(3):205-10. PubMed ID: 12614409
[TBL] [Abstract][Full Text] [Related]
14. Treating actinic keratoses with imiquimod.
Dixon A
Aust Fam Physician; 2007 May; 36(5):341-2. PubMed ID: 17492069
[TBL] [Abstract][Full Text] [Related]
15. Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle.
Berman B; Sullivan T; De Araujo T; Nadji M
Br J Dermatol; 2003 Nov; 149 Suppl 66():59-61. PubMed ID: 14616354
[TBL] [Abstract][Full Text] [Related]
16. Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial.
Peris K; Campione E; Micantonio T; Marulli GC; Fargnoli MC; Chimenti S
Dermatol Surg; 2005 Mar; 31(3):318-23. PubMed ID: 15841634
[TBL] [Abstract][Full Text] [Related]
17. Is imiquimod effective and safe for actinic keratosis?
Walker JK; Koenig C
J Fam Pract; 2003 Mar; 52(3):184-5. PubMed ID: 12620165
[TBL] [Abstract][Full Text] [Related]
18. Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.
Urosevic M; Dummer R; Conrad C; Beyeler M; Laine E; Burg G; Gilliet M
J Natl Cancer Inst; 2005 Aug; 97(15):1143-53. PubMed ID: 16077073
[TBL] [Abstract][Full Text] [Related]
19. Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer.
Garcia-Mouronte E; Berna-Rico E; de Nicolas-Ruanes B; Azcarraga-Llobet C; Alonso-Martinez de Salinas L; Bea-Ardebol S
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446011
[TBL] [Abstract][Full Text] [Related]
20. Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis.
Persaud AN; Shamuelova E; Sherer D; Lou W; Singer G; Cervera C; Lamba S; Lebwohl MG
J Am Acad Dermatol; 2002 Oct; 47(4):553-6. PubMed ID: 12271300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
